Bronchoectases: approach of the therapist and surgeon


Cite item

Full Text

Abstract

References

  1. Laennec R. T. H. A treatise on the disease of the chest. Forbes J. trans. New York: Library of the New York Academy of Medicine, Hafner Publishing; 1962. 8.
  2. Weycker D., Edelsberg J., Jster G., Tino G. Prevalence and economic burden of bronchiectasis. Clin. Pulm. Med. 2005; 12: 205-211.
  3. Reid L. M. Reduction in bronchial subdivision in bronchiectasis. Thorax 1950; 5: 233-247.
  4. Цигельник А. Я. Бронхоэктатическая болезнь. Л.: Медицина; 1968.
  5. Limper А. Н., Prakash U. S. B. Tracheobronchial foreign bodies in adults. Ann. lntern. Med. 1990; 112: 604-609.
  6. Kwon K. Y., Myers J. L., Swensen S. J., Colby T. V. Middle lobe syndrome: a clinicopathological study of 21 patients. Hum. Pathol. 1995; 26: 302-307.
  7. Barker A. F. Bronchictasis. N. Engl. J. Med. 2002; 346: 1383-1393.
  8. Nicotra M. B., Rivera M., Dale A. M. et al. Clinical, pathophysiologic, and microbiologic characterization of bronchiectasis in aging cohort. Chest 1995; 108: 955-961.
  9. Barker A. F. Clinical manifestations and diagnosis of bronchiectasis. Available at: www.uptodate.com.
  10. Hansell D. M. Bronchiectasis. Radiol. Clin. N. Am. 1998; 36: 107-128.
  11. Lynch D. A., Newell J., Hale V. et al. Correlation of CT findings with clinical evaluations in 261 patients with symptomatic bronchiectasis. Аm. J. Roentgenol. 1999; 173: 53-58
  12. Van der Bruggen-Bogaarts В. A. Н. А., van der Bruggen H. M. J. G., van Waes P. F. G. M., Lammers J. W. J. Assessment of bronchiectasis: comparison of HRCT and spiral volumetric CT. J. Comput. Assist. Tomogr. 1996; 20: 15-19.
  13. Kennedy M. P., Noone P. G., Leigh M. W. et al. High-resolution CT of patients with primary ciliary dyskinesia. Am. J. Roentgenol. 2007; 188: 1232-1239.
  14. Cartier Y., Kavanagh P. V., Jokkoh T. et al. Accuracy of high resolution CT in the differentiation of specific diseases. Am. J. Roentgenol. 1999; 173: 47-53.
  15. Sheehan R. E., Wells A. U., Copley S. J. et al. A comparison of serial computed tomography and functional change in bronchiectasis. Eur. Respir. J. 2002; 20: 581-587.
  16. Patel I. S., Vlahos I., Wilkinson T. M. et al. Bronchiectasis, exacerbation indices, and inflammation in chronic obstructive pulmonary disease. Am. J. Respir. Care Med. 2004; 170: 400-41З.
  17. Pang J., Chan H. S., Sung J. Y. Prevalence of asthma, atopy, and bronchial hyperreactivity in bronchiectasis: a controlled study. Thorax 1989; 44: 948-951.
  18. O'Donnel A. E., Barker A. F., llowite J. S., Fick R. B. Treatment of idiopathic bronchiectasis with aerosolized recombinant human DNase I. Chest 1998; 113: 1329-1334.
  19. Pasteur M. C., Helliwell S. M., Houghton S. J. et al. An investigation into causative factors in patients with bronchiectasis. Am. J. Respir. Crit. Care Med. 2000; 162: 1277-1284.
  20. Pang J. A., Cheng A., Chan H. S. et al. The bacteriology of bronchiectasis in Hong Kong investigated by protected catheter brush and bronchoalveolar lavage. Am. Rev. Respir. Dis. 1989; 139: 14-17.
  21. Angrill J., Agusti C., de Celis R. et al. Bacterial colonization in patients with bronchiectasis: microbiological pattern and risk factors. Thorax 2002; 57: 15-19.
  22. Kligman K. L., Pye A., Murphy T. F., Hill S. L. Dynamics of respiratory tract colonization by Bronhamella cаtаrrhalis in bronchiectasis. Am. J. Resp. Crit. Care Med. 1995; 152: 1072-1078.
  23. Angrill J., Augusti C., de Celis R. et al. Bronchial inflammation and colonization in patients with clinically stable bronchiectasis. Am. J. Respir. Crit. Care Med. 2001; 164: 1628-1632.
  24. Miszkiel K. A., Wells A. U., Rubens М. B. et al. Effects of airway infection by Pseudomonas aeruginosa: a computed tomographic study. Thorax 1997; 52: 260-264.
  25. Ho P. L., Chan K. N., Ip M. S. M. et al. The effect of Pseudomonos aeruginosa infection on clinical parameters in steady-state bronchiectasis. Chest 1998; 114: 594-859.
  26. Pang G., Clancy R., Cong M. et al. Influenza virus inhibits lysozyme secretion by sputum neutrophils in subjects with chronic bronchial sepsis. Am. J. Respir. Crit. Care Med. 2000; 161: 718-722.
  27. Woodhead M., Blasi F., Ewig S. et al. Guidelines for the management of adult lower respiratory tract infections. Eur. Respir. J. 2005; 26: 1138-1180.
  28. Rayner C. F., Tillotson G., Cole P. J., Wilson R. Efficacy and safety of long-term ciprofloxacin in the management of severe brochchiectasis. J. Antimicrob. Chemother. 1994; 34: 149-154.
  29. Tsang K. W., Ho P. I., Chan K. N. et al. A pilot study of low-dose erythromycin in bronchiectasis. Eur. Respir. J. 1999; 13: 361-365.
  30. Saiman L., Marshall B. C. Mayer-Hamblett N. et al. Azithromycin in patients with cystic fibrosis chronically infected with Pseudomonas aeruginosa: a randomized controlled trial. J. A. M. A. 2003; 290: 1749-1753.
  31. Страчунский Л. С., Козлов С. Н. Макролиды в современной клинической практике. Смоленск: Русич; 1998.
  32. Ramsey B. W., Pepe M. S., Quan J. M. et al. Intermittent administration of inhaled tobramycin in patients with cystic fibrosis. N. Engl. J. Med. 1999; 340: 23-29.
  33. Barker A. F., Couch L., Fiel S. B. et al. Tobramycin solution for inhalation reduces sputum Pseudomonas aeruginosa density in bronchiectasis. Am. J. Respir. Crit. Care Med. 2000; 162: 481-487.
  34. Scheinberg P., Shore E. A pilot study of the safety and efficacy of tobramycin solution for inhalation in patients with severe bronchiectasis. Chest 2005; 127: 1420-1425.
  35. Barker A. F. Treatment of bronchiectasis. Available at: www.uptodate.com.
  36. Sadikot R. T., Blackwell T. S., Christman J. W., Prince A. S. Pathogen-host interactions in Pseudomonas aeruginosa pneumonia. Am. J. Respir. Crit. Care Med. 2005; 171: 1209-1213.
  37. Martinez-Garcia M. A., Soler-Cataluna J. J., Perpina-Tordera M. et al. Factors associated with lung function decline in adult patients with stable non-cystic fibrosis bronchiectasis. Chest 2007; 132: 1565-1571.
  38. Griffith D. E., Aksamit T., Brown-Elliott В. A. et al. An official ATS/IDSA statement: diagnosis, treatment, and prevention of nontuberculous mycobacterial diseases. Am. J. Respir. Crit. Care Med. 2007; 175: 367-403.
  39. Wark P. A., Hensley M. J., Saltos N. et al. Anti-inflammatory effect of itraconazole in stable allergic bronchopulmonary aspergillosis: A randomized controlled trial. J. Allergy Clin. lmmunol. 2003; 111: 952-961.
  40. Kellett P. J., Redfern J., Niven R. M. Evaluation of nebulised hypertonic saline (7%) as an adjunct to physiotherapy in patients with stable bronchiectasis. Respir. Med. 2005; 99: 27-31.
  41. Daviskas E., Anderson S. D., Eberl S., Young I. H. Effect of increasing doses of mannitol on mucus clearance in patients with bronchiectasis. Eur Respir J. 2008; 31: 765-770.
  42. O'Donnell A., Barker A., llowite J. et al. Treatment of idiopathic bronchiectasis with aerosolized recombinant human DHase I. Chest 1998; 113: 329-333.
  43. Elborn J. S., Johnston B., Allen F. et al. Inhaled steroids in patients with bronchiectasis. Respir. Med. 1992; 86: 121-127.
  44. Tsang K. W., Tan K. C., Но Р. L. et al. Inhaled fluticasone in bronchiectasis: a 12 month study. Thorax 2005; 60: 239-244.
  45. Martinez-Garcia M. A., Perpina-Tordera M., Roman-Sanchez Р., Soler-Cataluna J. J. Inhaled steroids improve quality of life in patients with steady-state bronchiectasis. Respir. Med. 2006; 100: 1623-1629.
  46. Fujimoto T., Hillejan L., Stamatis G. Current strategy for surgical management of bronchiectasis. Ann. Thorac. Surg. 2001; 72: 1711-1715.
  47. Agasthian T., Deshchamps C., Trastek V. F. et al. Surgical management of bronchiectasis. Ann. Thorac. Surg. 1996; 62: 976-981.
  48. Balkanli K., Genc O., Dakak M. et al. Surgical management of bronchiectasis: analysis and short-term results in 238 patients. Eur. J. Cardiothorac. Surg. 2003; 24: 699-705.
  49. Giovannetti R., Alifano M., Stefani A. et al. Surgical treatment of bronchiectasis: early and long-term results. Interactive Cardiovasc. Thorac. Surg 2008; 7: 609-612.
  50. Keistinen T., Saynajakangas О., Tuuponen T., Kivela S. L. Bronchiectasis: an orphan disease with a poorly-understood prognosis. Eur. Respir. J. 1997; 10: 2784-2789.
  51. Dupont M., Gacouin A., Lena H. et al. Survival of patients with bronchiectasis after the first ICU stay for respiratory failure. Chest 2004; 125: 1815-1822.
  52. Alzeer A. H., Al-Mobeirek A. F., Al-Otair Н. A. et al. Right and left ventricular function and pulmonary artery pressure in patients with bronchiectasis. Chest 2008; 133: 468-473.

Supplementary files

Supplementary Files
Action
1. JATS XML
Download

Copyright (c) 2009 Consilium Medicum

Creative Commons License
This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.
 

Address of the Editorial Office:

  • Alabyan Street, 13/1, Moscow, 127055, Russian Federation

Correspondence address:

  • Alabyan Street, 13/1, Moscow, 127055, Russian Federation

Managing Editor:

  • Tel.: +7 (926) 905-41-26
  • E-mail: e.gorbacheva@ter-arkhiv.ru

 

 © 2018-2021 "Consilium Medicum" Publishing house


This website uses cookies

You consent to our cookies if you continue to use our website.

About Cookies